All News

The skin microbiomes of patients with breast cancer who received radiation therapy may affect whether they get radiation dermatitis, a study showed.

The Food and Drug Administration approved Rybrevant plus carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has EGFR exon 20 insertion mutations.

Cancer is such a life-altering event, that it’s hard to fathom being able to forget all memories associated with it, but I did my best to make it happen.

From TikTok singer Cat Janice dying of cancer to Taylor Swift giving a 9-year-old with brain cancer the “22” hat during a recent concert, here is what’s happening in the oncology space this week.

Consulting physical therapy early on and speaking up to the health care team can help patients with blood cancer be more prepared for a hematopoietic stem cell transplant, an expert said.

An oral suspension formula of Imbruvica received the green light from the Food and Drug Administration to be used in all approved indications.

In our issue of Heal Spring, we bring awareness to important topics, such as mental health after cancer treatment and how survivors can mend their minds.

I agree that cancer is portrayed very stereotypically in society, so here are some ways I think we can highlight the reality of cancer.

My late husband and I spent a week holding hands and talking, but between the darkness and his sleep mask, without eye contact.

The Food and Drug Administration has accepted a Biologics License Application for Tevimbra with chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Researchers on a phase 1b/2 trial dosed their first patient with samuraciclib and ARV-471, a novel treatment regimen for patients with a breast cancer subset.

After Tepmetko’s full approval for metastatic lung cancer treatment, patients should feel that the data from the accelerated approval is validated, an expert said.

“The biggest thing that I hate to see happen is that those conversations don't even happen [around cannabis and cancer],” said Dr. Brooke Worster.

Writing poetry was something that got me through cancer and helped heal my soul.

Try out these easy sauce recipes to add to a fresh salad or your favorite pasta dish, providing cancer survivors with a fun yet nutritious treat!

The FDA granted a breakthrough therapy designation to BAY 2927088 after it showed promise in treating patients with HER2 mutations.

A phase 2 trial showed that Trodelvy plus Keytruda had a high response rate with lasting responses, emphasizing “potential additive or synergistic effects,” an expert said.

Sociodemographic factors affect some survivors who may not have easy access to health care or healthy food, reducing their health-related quality of life.

Looking back on my experience with testicular cancer at a young age, I realize that cancer didn't define me — it helped shape me.

Michelle Anderson-Benjamin, who received a diagnosis of metastatic breast cancer in 2022, works as a death doula to provide end-of-life support to patients and their families.

Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.

The first patient has been enrolled in a clinical trial evaluating a reduced dose of post-transplant immunosuppressive chemotherapy cyclophosphamide for patients with blood cancers.

Mental health after cancer treatment has not been talked about enough, experts say, so how should survivors effectively care for their minds?

Accepting the unknown and understanding why random things happen helps me be hopeful as my daughter reached five years of cancer survivorship.

Orca-T outperformed post-transplant cyclophosphamide when it came to relapse-free survival and overall survival in patients with blood cancer who underwent a stem cell transplantation from a matched unrelated donor.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

Researchers on a phase 1/2 trial provided the first dose of gotistobart plus Pluvicto to a specific patient population with prostate cancer.

Patients who were obese tended to have an increased risk of moderate to severe GVHD after undergoing allogeneic hematopoietic cell transplantation, research showed.

After I was diagnosed with colon cancer, I learned to take care of myself more and be more outspoken than ever before.

Jakafi plus Rezurock showed promise in treating graft-versus-host disease in patients who underwent undergone allogeneic hematopoietic cell transplantation.